Id |
Subject |
Object |
Predicate |
Lexical cue |
T44 |
21-29 |
SP_7 |
denotes |
COVID-19 |
T19296 |
21-29 |
SP_7 |
denotes |
COVID-19 |
T45 |
47-53 |
UBERON:0002405 |
denotes |
immune |
T3907 |
47-53 |
UBERON:0002405 |
denotes |
immune |
T46 |
54-67 |
GO:0065007 |
denotes |
dysregulation |
T65562 |
54-67 |
GO:0065007 |
denotes |
dysregulation |
T47 |
71-81 |
CL:0000235;GO:0042116 |
denotes |
macrophage |
T99154 |
71-81 |
CL:0000235;GO:0042116 |
denotes |
macrophage |
T48 |
82-92 |
GO:0042116 |
denotes |
activation |
T21216 |
82-92 |
GO:0042116 |
denotes |
activation |
T49 |
112-123 |
UBERON:0001004 |
denotes |
respiratory |
T35889 |
112-123 |
UBERON:0001004 |
denotes |
respiratory |
T50 |
171-174 |
PR:000029150 |
denotes |
HLA |
T52417 |
171-174 |
PR:000029150 |
denotes |
HLA |
T51 |
181-185 |
PR:000001889 |
denotes |
CD14 |
T73916 |
181-185 |
PR:000001889 |
denotes |
CD14 |
T52 |
186-195 |
CL:0000576 |
denotes |
monocytes |
T86003 |
186-195 |
CL:0000576 |
denotes |
monocytes |
T53 |
261-269 |
SP_7 |
denotes |
COVID-19 |
T91561 |
261-269 |
SP_7 |
denotes |
COVID-19 |
T54 |
273-277 |
PR:000001393 |
denotes |
IL-6 |
T288 |
273-277 |
PR:000001393 |
denotes |
IL-6 |
T55 |
286-297 |
DG_35 |
denotes |
Tocilizumab |
T45776 |
286-297 |
DG_35 |
denotes |
Tocilizumab |
T56 |
316-326 |
SP_7 |
denotes |
SARS-CoV-2 |
T71931 |
316-326 |
SP_7 |
denotes |
SARS-CoV-2 |
T57 |
345-358 |
GO:0065007 |
denotes |
dysregulation |
T97850 |
345-358 |
GO:0065007 |
denotes |
dysregulation |